Literature DB >> 6125998

Distribution and metabolism of exogenous somatostatin in the rat.

G E Peters.   

Abstract

The mechanisms of clearance and degradation of injected [3H]somatostatin have been studied in the rat using octadecasilyl-silica extraction and HPLC separation methods.. Three apparent consecutive plasma half-lives of 1, 3 and 20 min were estimated following administration of a pharmacological dose. The initial rapid clearance was due to uptake by various tissue beds, mainly the large peripheral tissue masses muscle, skin and intestine which together accounted for 70% injected radioactivity at 1 min. By contrast the amounts taken up by liver and kidney were relatively small (less than 10%) despite the accumulation of higher concentrations. Massive degradation occurred following uptake and small fragments and amino acids were released into the circulation almost immediately. Inactivation by blood itself was negligible. A slow phase of decline observed at later times suggested a return of intact peptide from extravascular storage sites to sustain plasma concentrations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125998     DOI: 10.1016/0167-0115(82)90059-3

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  5 in total

1.  Extensive biliary excretion of the model opioid peptide [D-PEN2,5] enkephalin in rats.

Authors:  C Chen; G M Pollack
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

2.  Compartments in the organum vasculosum laminae terminalis of the rat and their delineation against the outer cerebrospinal fluid-containing space.

Authors:  B Krisch; H Leonhardt; A Oksche
Journal:  Cell Tissue Res       Date:  1987-11       Impact factor: 5.249

Review 3.  Somatostatin and somatostatin receptor physiology.

Authors:  Philip Barnett
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

4.  Effect of current magnitude and drug concentration on iontophoretic delivery of octreotide acetate (Sandostatin) in the rabbit.

Authors:  D T Lau; J W Sharkey; L Petryk; F A Mancuso; Z Yu; F L Tse
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

5.  The therapeutic effect of the neuropeptide hormone somatostatin on Schistosoma mansoni caused liver fibrosis.

Authors:  Shyama Chatterjee; Gunther Vrolix; Inge Depoortere; Theo Peeters; Eric Van Marck
Journal:  BMC Infect Dis       Date:  2005-06-10       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.